| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |